analog assay
A very small proportion of the total triiodothyronine (T3) in serum is unbound (1,2), but it is this free component that is considered to be the physiologically active form of T3.3 Various methods have been used to estimate free triiodothyronine (FF3); each has advantages and disadvantages. Previous methods, including equilibrium dialysis (3), ultrafiltration (4), Sephadex gel filtration (5), gas chromatography (6), and colunm adsorption chromatography (7) . are technically complicated and thus have limited applicability in the routine clinical laboratory. Recently, a simple radioimmunoassay was described (8) for detecting FF3, based on the use of T3-analog tracers that do not bind to serum thyroxinbinding globulin (TBG). However, it was reported that the T3-analog is bound significantly to serum albumin, as in an analog method for measurement of free thyroxin (9). Moreover, a nonisotopic immunoassay would be preferable for routine laboratory tests.
Previously, we reported on a highly specific enzyme immunoassay for measurement of free thyroxin, based on the use of T4-/3-r-galactosidase conjugate, in serum (10) and in dried-blood samples on filter paper (11). Here, we describe a new enzyme immunoassay for FF3 in which we used a conjugate of T3 with p-r-galactosidase that is not significantly influenced by either TBG or albumin. 
Materials and Methods

Materials
Chemicals:
4-(Maleimidomethyl)-cyclohexane-1-carboxyl ic acid succiimide ester was from Zieben Chemical Co. Ltd., Tokyo, Japan. i -T3 (free acid) and o-nitrophenyl-/3-n galactopyranoside were from Sigma Chemical Co., St. Louis MO 63178. /3-n-Galactosidase (EC 3.2. We could measure FF3 in serum in concentrations ranging from 0.7 to 26 ng/L.
Results
Binding
Precision:
As shown in Table 1 , the within-assay coefficients of variations (CVs) were 4.0 to 9.0 (mean 6.1) %, and the between-assay CVs were 7.9 to 11.5 (mean 9.5) %. 
